Divya A. Chari

Divya A. Chari

Auto-generated profile, based on publicly available information

Divya A. Chari

Eaton-Peabody Laboratories, Massachusetts Eye and Ear, Boston, MA, USA; Department of Otolaryngology-Head and Neck Surgery, Harvard Medical School, Boston, MA, USA; University of Massachusetts Chan Medical School, Worcester, MA, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 August 2022 in Journal of Neurology
Verified
Journal Article
Closed access
PDF file
DCDivya A. Chari
Divya A. Chari
AMAmsal Madhani
Amsal Madhani
JSJeffrey D. Sharon
Jeffrey D. Sharon
RLRichard F. Lewis
Richard F. Lewis

18 February 2021 in Otology & Neurotology
Verified
Journal Article
Closed access
DCDivya A. Chari
Divya A. Chari
YLYu-Hsi Liu
Yu-Hsi Liu
JCJanice J. Chung
Janice J. Chung
SRSteven D. Rauch
Steven D. Rauch
Objective: Cognitive symptoms in patients with vestibular disorders are far from rare, but identification of patients at risk for cognitive impairment remains poor. The Dizziness Handicap Inventory (DHI) is a widely used patient-reported outcome questionnaire for dizzy patients with several questions that address cognitive function. However, the relationship between subjective cognitive symptomatology in patients with vestibular disorders and performance on DHI is poorly characterized. Study Design: Retrospective cohort study. Setting: Tertiary care vestibular clinic. Subjects: Individuals with diagnoses of vestibular migraine (VM), Menière's disease (MD), and concomitant vestibular migraine and Menière's disease (VMMD) presenting to clinic between January 2007 and December 2019. Results: Of 761 subjects, 365 had VM, 311 had MD, and 85 had VMMD. Symptoms of brain fog and chronic fatigue occurred more frequently in the VM and VMMD groups compared with the MD group (χ 2 (df = 2, n = 761) = 67.8, 20.9, respectively, p < 0.0001). DHI scores were significantly higher in patients with VM and VMMD compared with those with MD (F[2,758] = 63.5, p < 0.001). A DHI score ≥ 13 suggested that the patient suffered from brain fog (sensitivity = 47.4%, specificity = 72.3%), whereas a score ≥ 15 indicated that the patient complained of chronic fatigue (sensitivity = 81.5%, specificity = 57.7%). Conclusion: Our results indicate a high prevalence of interictal cognitive symptoms in patients with episodic vestibular disorders. The DHI cannot be reliably used to differentiate between vestibular disorders nor detect cognitive impairment in these patient populations. Alternative methods must be used to identify vestibulopathic patients with cognitive symptoms to initiate strategies for prevention and treatment.

16 May 2025 in Frontiers in Neurology
Verified
Journal Article
Open access
PDF file
DCDivya A. Chari
Divya A. Chari
ABArpan Bose
Arpan Bose
KRKimberly Ramirez
Kimberly Ramirez
PRPaula Robles-Bolivar
Paula Robles-Bolivar
KLKuei-You Lin
Kuei-You Lin
AEAndreas H. Eckhard
Andreas H. Eckhard
Prosper Meniere made his immortal contribution to the field of otology in 1861. At that time, all manner of “fits” were lumped together under the diagnosis of “apoplectiform cerebral congestion”—too much blood in the brain. His genius was to identify a specific subset of this heterogeneous pool whose cardinal symptoms, tinnitus, fluctuating progressive deafness, and episodic vertigo, were due to dysfunction of the inner ear. Seventy-seven years later, in 1938, Hallpike and Cairns in England and Yamakawa in Japan identified cochleosaccular endolymphatic hydrops (EH) as the histopathologic correlate of Meniere’s disease (MD). Over the 85 years since then, many theories to explain the symptoms of MD have come and gone. A consensus has slowly emerged that patients with this condition have a failure of inner ear homeostasis. The cause(s) of this homeostatic failure and the mechanism(s) by which this failure leads to fluctuating progressive sensorineural hearing loss and episodic vertigo has remained elusive. In the last few years, new techniques and findings in temporal bone histopathology and in vivo temporal bone imaging have yielded breakthroughs in this field. We are now recapitulating Meniere’s approach by taking the heterogeneous population of patients with MD and segregating them into specific subtypes based upon clinical phenotype. Salient clinical features include vestibular aqueduct and endolymphatic sac morphology, age at symptom onset, sex, and incidence of bilateral involvement. Furthermore, new imaging modalities enable unequivocal diagnosis of EH, transitioning MD from a “clinical” diagnosis to one based upon specific objective criteria. These breakthroughs have opened the door to genetic analyses, consideration of comorbid clinical disorders, especially migraine, and potential new treatments, and demand that we revisit all the various treatments that have been considered previously. They also demand new and more stringent criteria for any publication about this condition. In this paper we will review these new findings, discuss their immediate implications for clinical practice, and consider some of the most pressing research questions for near- and long-term address.

6 October 2022 in Otology & Neurotology
Verified
Journal Article
Closed access
MAMaimuna Ahmad
Maimuna Ahmad
LBLukasz Bola
Lukasz Bola
ABAnissa Boutabla
Anissa Boutabla
SKSusan King
Susan King
RLRichard F. Lewis
Richard F. Lewis
DCDivya A. Chari
Divya A. Chari
Objective: To characterize visuospatial and nonvisuospatial cognitive domains affected by vestibular loss and determine whether patient-reported outcomes measures (PROMs) correlate with performance on neuropsychological tests. Study Design: Cross-sectional study. Setting: University-based tertiary medical center. Patients: Sixty-nine age-matched subjects: 25 patients with bilateral vestibular loss (BVL), 14 patients with unilateral vestibular loss (UVL), and 30 normal controls (NC). Interventions: Neuropsychological tests used to assess visuospatial and auditory short-term and working memory, number magnitude representation, executive function, and attention. Validated PROMs used to evaluate quality of life and subjective cognitive impairment. Main Outcome Measures: Performance on neuropsychological tests and scores on PROM surveys. Results: BVL and UVL patients performed significantly worse than NC subjects on tasks requiring visuospatial representation compared with NC subjects (p < 0.01). BVL patients demonstrated decreased performance on spatial representation tasks compared with UVL and NC subjects (p < 0.05 and p < 0.05, respectively). All subject groups performed similarly on tasks assessing nonvisuospatial cognitive domains, such as auditory short-term and working memory, executive function, and attention. PROMs did not seem to correlate with performance on neuropsychological tasks. Conclusion: Patients with vestibular loss exhibit impairments in tasks requiring visuospatial representation but perform similarly to NC subjects in tasks of auditory working memory, executive function, or attention. Currently available questionnaires may be insufficient to screen patients for cognitive deficits.

1 January 2024 in Journal of Otology
Verified
Journal Article
Open access
CFCameron B. Fattahi
Cameron B. Fattahi
CZChristopher Zaro
Christopher Zaro
JCJanice J. Chung
Janice J. Chung
RLRichard F. Lewis
Richard F. Lewis
DCDivya A. Chari
Divya A. Chari
Bithermal caloric irrigation, video head impulse test (vHIT), and rotational testing are commonly used to assess peripheral vestibular function, but the relative clinical utility of each test in differentiating patients with peripheral vestibulopathy is debated. To determine whether (1) the combination of two or more vestibular tests enhances diagnostic utility over a single test; (2) abnormal test results on vestibular tests correlate with one another. Retrospective analysis of data collected from multidisciplinary vestibular clinics at two academic medical centers from 2016 to 2022. 150 patients (54.10 ± 15.09 years, 88 females) were included. No individual test was significantly better at predicting the presence of peripheral vestibular damage (p > 0.05). vHIT test results improved significantly when combined with either the caloric test (p = 0.007) or rotary chair test (p = 0.039). Caloric and rotational testing had high sensitivity (74.65% and 76.06%, respectively) and specificity (83.54% and 78.48%, respectively). vHIT demonstrated excellent specificity (89.87%) but poor sensitivity (47.89%). Caloric, vHIT, and rotary chair tests results did not correlate with one another (p > 0.05). Vestibular function tests have comparable diagnostic utility, yet each offers unique advantages. Caloric and rotational testing may be best suited for screening peripheral damage and vHIT may function ideally as a confirmatory test.

5 October 2021 in Otolaryngology–Head and Neck Surgery
Verified
Journal Article
Open access
PDF file
AGAlejandro Garcia
Alejandro Garcia
DCDivya A. Chari
Divya A. Chari
KSKonstantina Stankovic
Konstantina Stankovic
DLDaniel J. Lee
Daniel J. Lee
EKElliott D. Kozin
Elliott D. Kozin
KFKevin H. Franck
Kevin H. Franck
During the COVID‐19 pandemic, the utility of portable audiometry became more apparent as elective procedures were deferred in an effort to limit exposure to health care providers. Herein, we retrospectively evaluated mobile‐based audiometry in the emergency department and outpatient otology and audiology clinics. Air conduction thresholds with mobile audiometry were within 5 dB in 66% of tests (95% CI, 62.8%‐69.09%) and within 10 dB in 84% of tests (95% CI, 81.4%‐86.2%) as compared with conventional audiometry. No significant differences were noted between mobile‐based and conventional audiometry at any frequencies, except 8 kHz (P <. 05). The sensitivity and specificity for screening for hearing loss were 94.3% (95% CI, 91.9%‐96.83%) and 92.3% (95% CI, 90.1%‐94.4%), respectively. While automated threshold audiometry does not replace conventional audiometry, mobile audiometry is a promising screening tool when conventional audiometry is not available.